These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28187499)

  • 1. Botulinum toxin type A in the treatment of facial myotonia in Schwartz-Jampel syndrome.
    Bandeira ID; Jagersbacher JG; Barretto TL; Santos CV; Lucena R
    Muscle Nerve; 2017 Aug; 56(2):E10-E11. PubMed ID: 28187499
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin A injections for the treatment of Schwartz-Jampel syndrome: a case series.
    Aburahma SK; Al-Khateeb T; Alrefai A; Amarin Z
    J Child Neurol; 2009 Jan; 24(1):5-8. PubMed ID: 19168812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schwartz-Jampel syndrome: surgical management of the myotonia-induced blepharospasm and acquired ptosis after failure with botulinum toxin A injections.
    Morrison DA; Mellington FB; Hamada S; Moore AT
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):57-9. PubMed ID: 16418670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of myotonia with carbamazepine in three cases with the Schwartz-Jampel syndrome.
    Topaloğlu H; Serdaroğlu A; Okan M; Gücüyener K; Topçu M
    Neuropediatrics; 1993 Aug; 24(4):232-4. PubMed ID: 8232784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal diagnosis of Schwartz-Jampel syndrome with dramatic response to carbamazepine.
    Squires LA; Prangley J
    Pediatr Neurol; 1996 Sep; 15(2):172-4. PubMed ID: 8888056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Blepharospasm in Schwartz-Jampel Syndrome: Botulinum Toxin A Injection or Surgery.
    Kashkouli MB; Shahrzad S; Jazayeri AA; Abtahi MB
    Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S47-S49. PubMed ID: 26020714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schwartz-Jampel syndrome: report of one case.
    Yang MT; Yang CC; Chu LW; Lee WT; Young C; Wang PJ
    Acta Paediatr Taiwan; 2002; 43(4):220-3. PubMed ID: 12238912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Facial palsy sequel and botulinum toxin].
    Benichou L; Labbe D; Le Louarn C; Guerreschi P
    Ann Chir Plast Esthet; 2015 Oct; 60(5):377-92. PubMed ID: 26432177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
    Habek M; Adamec I; Gabelić T; Brinar VV
    Acta Neurol Belg; 2012 Dec; 112(4):423-4. PubMed ID: 22669610
    [No Abstract]   [Full Text] [Related]  

  • 11. Botulinum toxin-induced immobilization of lower facial wounds.
    Gassner HG; Sherris DA; Friedman O
    Arch Facial Plast Surg; 2009; 11(2):140-2. PubMed ID: 19289689
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
    Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
    Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin and facial palsy. Our experience].
    Navarrete Alvaro ML; Junyent J; Torrent L
    Acta Otorrinolaringol Esp; 2010; 61(4):277-81. PubMed ID: 20400055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating childhood hyperhidrosis with botulinum toxin type A.
    Bhakta BB; Roussounnis SH
    Arch Dis Child; 2002 Jan; 86(1):68. PubMed ID: 11806899
    [No Abstract]   [Full Text] [Related]  

  • 15. Botulinum toxin A in anti-GAD-positive stiff-limb syndrome.
    Anagnostou E; Zambelis T
    Muscle Nerve; 2012 Sep; 46(3):457-8. PubMed ID: 22907242
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin in myotonia congenita: it does not help against rigidity and pain.
    Dressler D; Adib Saberi F
    J Neural Transm (Vienna); 2014 May; 121(5):531-2. PubMed ID: 24357052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyotonia in a muscle flap producing a convulsing breast: successful treatment with botulinum toxin.
    Schwartz MS; Wren DR; Filshie J
    Mov Disord; 1998 Jan; 13(1):188-90. PubMed ID: 9452354
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Frey's syndrome with botulinum toxin].
    Acher-Chenebaux A; Maillard H; Potier A; Lejoyeux P; Célérier P
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 1):703-5. PubMed ID: 16230925
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinum toxin for the treatment of facial flushing.
    Yuraitis M; Jacob CI
    Dermatol Surg; 2004 Jan; 30(1):102-4. PubMed ID: 14692937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of botulinum toxin a in the establishment of symmetry in pediatric paralysis of the lower lip.
    Haykal S; Arad E; Bagher S; Lai C; Hohman M; Hadlock T; Zuker RM; Borschel GH
    JAMA Facial Plast Surg; 2015; 17(3):174-8. PubMed ID: 25742503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.